Goldberg Andrew D.
SEC CIK 1827722 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals, Inc. | Dir | 19.7K | $19.0K | — | 6 | 2023-06-16 | 2026-06-12 |
Most active insiders at TARS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Azamian Bobak R. | Pres, CEO, Board COB, Dir | — | $5.51M |
| 2 | LINK WILLIAM J PHD | Dir | — | $4.48M |
| 3 | Whitfield Dianne C. | CHRO | — | $2.69M |
| 4 | Lin Elizabeth Yeu | Chief Medical Off | — | $2.36M |
| 5 | Neervannan Seshadri | COO | — | $2.00M |
| 6 | Farrow Jeffrey S | See Remarks | — | $1.32M |
| 7 | Mottiwala Aziz | Chief Commercial Off | — | $892.5K |
| 8 | Wahl Bryan | GC | — | $850.4K |
| 9 | Goodrich Katherine | Dir | — | $183.4K |
| 10 | Goldberg Andrew D. | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-16 16:05 | 2026-06-12 | TARS | Tarsus Pharmaceuticals, Inc. | Goldberg Andrew D. | Dir | M - OptEx | — | +2,954 | 19.7K | +18% | — |
| D | 2025-06-16 | 2025-06-13 | TARS | Tarsus Pharmaceuticals, Inc. | Goldberg Andrew D. | Dir | M - OptEx | — | +3,350 | 16.7K | +25% | — |
| D | 2025-03-11 | 2025-03-07 | TARS | Tarsus Pharmaceuticals, Inc. | Goldberg Andrew D. | Dir | M - OptEx | $12.89 | +7,000 | 13.3K | +110% | +$90.2K |
| D | 2024-06-25 | 2024-06-24 | TARS | Tarsus Pharmaceuticals, Inc. | Goldberg Andrew D. | Dir | M - OptEx | — | +3,350 | 6,350 | +112% | — |
| 2023-12-19 | 2023-12-15 | TARS | Tarsus Pharmaceuticals, Inc. | Goldberg Andrew D. | Dir | P - Purchase | $18.96 | +1,000 | 3,000 | +50% | +$19.0K | |
| D | 2023-06-21 | 2023-06-16 | TARS | Tarsus Pharmaceuticals, Inc. | Goldberg Andrew D. | Dir | M - OptEx | — | +2,000 | 2,000 | New | — |
Purchase Sale Sale after option exercise All abbreviations